Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Wright Medical Is Up 5.7% (WMGI)
Comtex SmarTrend(R) - Mon May 12, 11:13AM CDT
When Wright Medical (NASDAQ:WMGI) reported earnings 12 days ago on April 30th, 2014, analysts, on average, expected the company to report a loss of $0.42 on sales of $69.3 million. Wright Medical actually reported a loss of $0.34 per share on sales of $71.1 million, beating EPS estimates by $0.08 and beating revenue estimates by $1.7 million. Shares of Wright Medical have climbed from $27.35 to $28.90, representing a gain of 5.7% since the company reported earnings 12 days ago.
Technical Data on Health Care Sector Equities -- Research on Volcano, Masimo, Wright Medical, and Sirona Dental Systems
PR Newswire - Fri May 09, 11:00AM CDT
On Thursday, May 08, 2014, the NASDAQ Composite ended at 4,051.50, down 0.40%, the Dow Jones Industrial Average finished the day 0.20% higher at 16,550.97, and the S&P 500 closed at 1,875.63, down 0.14%. During the trading session, five out of ten sectors finished positive. The S&P 500 Health Care Sector Index ended the day at 664.48, down 0.53%, while the index has advanced 0.78% in the last one month. Investor-Edge has initiated coverage on the following equities: Volcano Corporation (NASDAQ: VOLC), Masimo Corporation (NASDAQ: MASI), Wright Medical Group Inc. (NASDAQ: WMGI) and Sirona Dental Systems Inc. (NASDAQ: SIRO). Free technical research on VOLC, MASI, WMGI and SIRO can be downloaded upon signing up at:
Wright Medical Group Sees Broader Q1 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 06, 11:30AM CDT
For 2014, Wright Medical Group, Inc. (WMGI) anticipates adjusted loss per share in the range of $1.28 to $1.38.
Upgrade Alert for Wright Medical (WMGI)
Comtex SmarTrend(R) - Thu May 01, 7:02AM CDT
Wright Medical (NASDAQ:WMGI) was upgraded from Buy to Strong Buy at Needham today. The stock closed yesterday at $27.35 on volume of 1.0 million shares, above average daily volume of 542,000. Wright Medical Group, Inc., an orthopedic device company, specializes in the design, manufacture, and marketing of reconstructive joint devices and bio-orthopedic materials. The Company's joint devices are used to replace knee, hip, and other joints that have deteriorated through disease or injury.
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Wright Medical Group, Inc. Reports 2014 First Quarter Financial Results
Business Wire - Wed Apr 30, 3:01PM CDT
--First Quarter Sales from Continuing Operations Increase 26% As Reported and 26% Constant Currency
Shares of WMGI Down 11.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Apr 28, 9:38AM CDT
SmarTrend identified a Downtrend for Wright Medical (NASDAQ:WMGI) on March 27th, 2014 at $30.73. In approximately 1 month, Wright Medical has returned 10.98% as of today's recent price of $27.35.
Health Care Sector Stocks under Review -- Research on Wright Medical, Globus Medical, Intuitive Surgical, and Accuray
PR Newswire - Tue Apr 15, 10:03AM CDT
The trading session on Monday, April 14, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,173.24, up 0.91% and the NASDAQ Composite closed at 4,022.69, up 0.57%. The S&P 500 finished the session 0.82% higher at 1,830.61. The gains were broad based as all the ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has lost 1.86% in the last three months. Investor-Edge has initiated coverage on the following equities: Wright Medical Group Inc. (NASDAQ: WMGI), Globus Medical Inc. (NYSE: GMED), Intuitive Surgical Inc. (NASDAQ: ISRG) and Accuray Inc. (NASDAQ: ARAY). Free technical research on WMGI, GMED, ISRG and ARAY can be downloaded upon signing up at:
Why Wright Medical (WMGI) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:58AM CDT
Wright MedicaL has witnessed a significant price decline in the past four weeks and negative earnings estimate revisions for the current quarter and the current year, making it time for investors to sell it off.
Wright Medical Group, Inc. to Host First Quarter 2014 Earnings Conference Call
Business Wire - Wed Apr 09, 5:00AM CDT
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Wednesday, April 30, 2014, at 3:30 p.m. Central Time to discuss the Company's operating results for its first quarter ended March 31, 2014. Operating results will be released at 3:00 p.m. Central Time that day.
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Wright Medical Group Inc. Regarding Possible Breaches of Fiduciary Duty
PR Newswire - Tue Apr 01, 5:50PM CDT
Levi & Korsinsky, LLP is investigating Wright Medical Group Inc. (NasdaqGS: WMGI) in connection with possible claims of breaches of fiduciary duty by certain of the members of the board of directors of the Company.
Wright Medical Group Reaches Agreement with ODE - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:20PM CDT
Last year, FDA issued a "not-approvable letter" in response to the PMA application submitted by Wright Medical Group for Augment Bone Graft.
Wright Medical Group, Inc. Announces Agreement with FDA Office of Device Evaluation to File PMA Amendment for Augment(R) Bone Graft In Lieu of Dispute Resolution Panel
Business Wire - Mon Mar 10, 4:23PM CDT
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced it has reached an agreement with the Office of Device Evaluation (ODE) of the U.S. Food and Drug Administration (FDA) under which ODE will accept a further amendment to the Pre-Market Approval application (PMA) for Augment(R) Bone Graft in lieu of proceeding with the Dispute Resolution Panel (DRP) that was scheduled for the week of May 19, 2014. The agreement with ODE remains subject to final approval by the FDA appeal authority. That approval is expected shortly.
Post Earnings Update: Wright Medical Has Sunk 6.0% Lower in Past 2 Weeks (WMGI)
Comtex SmarTrend(R) - Mon Mar 10, 7:38AM CDT
When Wright Medical (NASDAQ:WMGI) reported earnings two weeks ago on February 24th, 2014, analysts, on average, expected the company to report a loss of $0.18 on sales of $65.0 million. The company actually reported a loss of $0.17 per share on sales of $67.8 million, beating EPS estimates by $0.01 and beating revenue estimates by $2.8 million. Shares of Wright Medical have slipped from $33.80 to $31.77, representing a loss of 6.0%, since the company reported earnings 14 days ago.
Nordion Signs Two-Year Strontium-82 Supply Contract with Bracco Diagnostics
Business Wire - Tue Mar 04, 7:01AM CST
Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it has entered into a two-year contract with Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, to supply strontium-82, a cyclotron based medical isotope produced both at Nordion's Vancouver, British Columbia and Ottawa, Ontario facilities.
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
Wright Medical Group Sees Wider Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 9:00AM CST
For full-year 2013, Wright Medical Group posted a wider adjusted loss of $25.2 million or 48 cents per share compared with $3.8 million or 10 cents per share in 2012.
Wright Medical Group, Inc. Reports 2013 Fourth Quarter and Full-Year Financial Results and Provides 2014 Guidance
Business Wire - Mon Feb 24, 3:00PM CST
--Fourth Quarter Global Foot and Ankle Net Sales Increase 22% As Reported and 22% Constant Currency